Allred Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Allred Capital Management's EW Position: Q1 2026 in Review
Allred Capital Management increased its Edwards Lifesciences (EW) stake by 48% in Q1 2026, buying an estimated $235K and bringing the position to 8,805 shares worth $705K. The position accounts for 0.26% of the portfolio, ranked #84.
Allred Capital Management first reported a position in EW in Q4 2019 and has held it in 24 quarters since. The position peaked at $839K in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Allred Capital Management held 8,805 shares of Edwards Lifesciences worth $705K as of Q1 2026.
- Allred Capital Management bought 2,846 Edwards Lifesciences shares in Q1 2026, an estimated $235K.
- Edwards Lifesciences made up 0.26% of Allred Capital Management's portfolio in Q1 2026, its #84 holding.
- Allred Capital Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 24 quarters since.
- Allred Capital Management's Edwards Lifesciences position peaked at $839K in Q2 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Allred Capital Management's 13F filing for Q1 2026, filed 14 May 2026.